-
The innovation achievements of pharmaceutical companies have gradually emerged, and the sales of a number of new Chinese medicine drugs have grown steadily
Time of Update: 2022-10-25
The sales of three innovative patented traditional Chinese medicines, Tongxinluo capsules, Sansong Yangxin capsules and Qilang Qiangxin capsules, which are laid out by Yiling Pharmaceutical in the field of cardiovascular and cerebrovascular diseases, have also steadily increased in recent years, with compound growth rates of 9.
-
Domestic pharmaceutical companies are constantly ushering in new breakthroughs in the field of new anti-tumor drugs
Time of Update: 2022-10-25
On October 19, it was reported that the clinical trial application of anti-tumor bispecific antibody injection (SIM0348) submitted by Simcere Pharmaceutical has been accepted by the State Food and Drug Administration and is intended to be used to carry out clinical trials for the treatment of advanced malignant tumors.
-
The large-scale planting of traditional Chinese medicinal materials helps enrich the people and increase income and promotes rural revitalization
Time of Update: 2022-10-25
Zhangxian is located in the south-central part of Gansu Province, located in the transition zone of the West Qinling Mountains and the Loess Plateau, with an average altitude of more than 1,800 meters, which is suitable for the cultivation of traditional Chinese medicinal materials.
-
Has the "proportion of medicine" changed its taste? Hospital assessment urgently needs to be refined!
Time of Update: 2022-10-25
The reform of medical insurance payment methods from charging by service items to paying for budget management is in full swing across the country. The basic principle of the reform is to partially s
-
Will the eighth batch of collective procurement include biosimilars? 180 companies compete for the 10 billion market!
Time of Update: 2022-10-25
With the end of the seventh batch of collective procurement, the eighth batch of collective procurement has become a hot topic in the industry. Among them, the widely concerned "biological drug colle
-
More than a year after taking office, the CEO of this pharmaceutical company joined the "resignation army"!
Time of Update: 2022-10-25
On October 21, Ridge Pharma announced that Mr. Hua Fengmao applied to resign as a director, chief executive officer (CEO), special committee of the board of directors and subsidiaries of the company due to personal reasons.
-
Will tumor genetic testing be included in centralized procurement? The official reply is coming!
Time of Update: 2022-10-25
In addition, whether tumor genetic testing projects will be included in the procurement with quantity, the National Medical Insurance Administration said: "Tumor genetic testing is a medical service project, and according to the current policy, the basic medical services provided by public medical institutions are subject to government guidance prices.
-
2023 China (Beijing) Smart Display and System Integration Exhibition
Time of Update: 2022-10-25
2023 China (Beijing) Smart Display and System Integration Exhibition China (Beijing) Smart Display and System Integration Exhibition2023 【Basic Information】 When: June 16-18, 2023 Venue: Beijing Etro
-
After dental implants, 15 provinces orthodontic brackets are collected!
Time of Update: 2022-10-25
Ceramic bracket category, such as the national 27-digit medical insurance code declared by the enterprise (standard set is 20, complete tooth position) contains both ceramic brackets and metal brackets, directly into the negotiation link, after successful negotiation, the product does not calculate the ranking, does not participate in the remaining amount allocation, and determines the agreed purchase amount according to 60% of the demand of medical institutions.
-
Pharmaceutical companies raise funds frequently, and most of the funds are used for innovation and research and development
Time of Update: 2022-10-25
In this IPO of the Science and Technology Innovation Board, Baiduoan intends to raise 760 million yuan for medical catheter industrialization upgrade projects, R&D center construction projects, marketing service network and information construction projects, and supplementary working capital projects.
-
Local innovative pharmaceutical companies are on the rise, and another multinational pharmaceutical company executive has chosen to join
Time of Update: 2022-10-25
Recently, Sihe Gene released news announcing that Huang Yue, former head of translational medicine at Merck China, officially joined Sihe Genomics as the Chief Translational Science Officer (CTO), fully responsible for the preclinical and clinical research and development of Sihe Gene's independent innovation antisense oligonucleic acid drug research and development project.
-
Tailor-made [Cloud Interview] The exclusive appointment channel of the Visual Environment Club is now open
Time of Update: 2022-10-25
The 2022 FERC Autumn Exhibition, which will be held from November 8th to November 14th, will be held at the same time as the ECE Summit Forum, cloud interviews, PPT presentations, and new product launches, which is your favorite?
-
Investment and layout of artificial intelligence have become an important part of the competition of pharmaceutical giants
Time of Update: 2022-10-25
Therefore, in order to improve R&D efficiency and reduce R&D investment, with the continuous development of science and technology in recent years, more and more companies and researchers have begun to apply "artificial intelligence" to pharmaceutical R&D and market, trying to further improve the success rate of new drug research and development through artificial intelligence technology AI algorithms, reduce manufacturing costs and R&D time.
-
NMPA: Revised the instructions for 4 varieties such as pentoxifylline injection
Time of Update: 2022-10-25
） Source: NMPA Editor: wangxinglai2004 On October 18, 2022, the State Food and Drug Administration issued an announcement that, based on the results of adverse drug reaction assessment, in order to further protect the safety of public drug use, the State Medical Products Administration decided to uniformly revise the content of the instructions of pentoxifylline injection (including pentoxifylline injection, pentoxifylline for injection, pentoxifylline sodium chloride injection, pentoxifylline glucose injection).
-
Antibodies, gene drugs, etc. are developing rapidly, and the bioreactor market is rising
Time of Update: 2022-10-25
As a key industry in the 14th Five-Year Plan, the biopharmaceutical industry is supported by favorable policies, and the clinical demand for biological drugs is becoming increasingly urgent, making the domestic biopharmaceutical industry develop actively, including antibodies, gene drugs and other hot areas are being deployed by more and more pharmaceutical companies by biological pharmaceutical companies, and the future potential is huge.
-
81 new Chinese medicine pieces will be included in the province's medical insurance payment coverage!
Time of Update: 2022-10-25
js?cdnversion='+~(-new Date()/36e5)]; In recent years, traditional Chinese medicine has received different degrees of policy support in terms of strategic position, standardized development mode, price, payment end, medical insurance immunization, sales end and innovation rhythm.
-
More than 20 billion yuan of anti-anemia drug market, domestic pharmaceutical companies are actively layout
Time of Update: 2022-10-25
45 billion yuan in 2021, and it is expected that the scale of China's anti-anemia drug market will reach 26.
45 billion yuan in 2021, and it is expected that the scale of China's anti-anemia drug market will reach 26.
-
The State Food and Drug Administration issued the 6th batch of reference preparations for generic drugs
Time of Update: 2022-10-25
0mg Janssen-Cilag/Karo Pharma No original drugs have been imported Added licensee Karo Pharma 42-36 Paroxetine hydrochloride tablets Paroxetine Hydrochloride Tablets 20mg (in terms of C19H20FNO3) Sino-American Tianjin SmithKline Pharmaceutical Co.
-
Under the "involution" of the generic drug market, domestic pharmaceutical companies are accelerating their "going abroad"
Time of Update: 2022-10-25
On October 19, Huahai Pharmaceutical announced that the new drug abbreviated application for dimethyl fumarate sustained-release capsules (ANDA, that is, the US generic drug application) declared to the US Food and Drug Administration (FDA) has been approved.
-
Macao hosted the 2022 Global Summit on the Digitalization of Traditional Chinese Medicine
Time of Update: 2022-10-25
(End) On October 21, the "9th Annual Conference of the Chinese Medicine Appraisal Professional Committee of the World Federation of Chinese Medicine Societies" and the "2022 Global Summit Forum on the Digitalization of Chinese Medicine" were officially opened in Macao.
